From hundreds of seizures to school every day
Lauryn Bowers had her first seizure at six months old. By the summer of 2019, aged four, she was fed through a tube and could no longer hold up her head, talk or crawl. Her mother, Carol Bowers of Aberdeen, was initially sceptical of medical cannabis because of the stigma around it, until she watched a BBC documentary. Since 2020 Lauryn has taken Bedrolite oil, at a cost of £1,000 a month that the family pays privately, helped by fundraising including a golf tournament. Her seizures fell from too many to count to about one every eight weeks, and she now happily goes to school every day.
*“It just makes you sick to your stomach with worry.” — Carol Bowers*
Bowers has been told Bedrolite supplies could run out in December. According to Matt Hughes, chief executive of the charity Medcan Family Foundation, without this treatment children like Lauryn would now be in palliative care or no longer alive.
The collapse of a sole supplier
Since 2003, Bedrocan has been the sole contracted grower for the Office of Medicinal Cannabis, an arm of the Dutch health ministry that holds a legal monopoly on buying, selling, importing and exporting the drug. Key facts about the company include:

















